First Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,645
Closed -$215K 110
2022
Q1
$215K Buy
1,645
+112
+7% +$14.6K 0.2% 99
2021
Q4
$234K Buy
1,533
+38
+3% +$5.88K 0.2% 94
2021
Q3
$242K Buy
+1,495
New +$252K 0.23% 87
2021
Q1
$216K Buy
+1,432
New +$227K 0.21% 97

Other funds holding IBB

First Bancorp's IBB Position: Q2 2022 in Review

First Bancorp sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 1,645 shares — an estimated $215K sold.

First Bancorp first reported a position in IBB in Q1 2021 and held it in 4 quarters. The position peaked at $242K in Q3 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • First Bancorp reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • First Bancorp sold 1,645 iShares Biotechnology ETF shares in Q2 2022, an estimated $215K.
  • First Bancorp first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 4 quarters.
  • First Bancorp's iShares Biotechnology ETF position peaked at $242K in Q3 2021.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on First Bancorp's 13F filing for Q2 2022, filed 14 Jul 2022.